The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
The global Newborn Screening for SMA and SCID market was valued at US$ 129.2 million in 2023 and is anticipated to reach US$ 288 million by 2030, witnessing a CAGR of 11.5% during the forecast period 2024-2030.
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
This report aims to provide a comprehensive presentation of the global market for Newborn Screening for SMA and SCID, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening for SMA and SCID.
Report Scope
The Newborn Screening for SMA and SCID market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Newborn Screening for SMA and SCID market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn Screening for SMA and SCID companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Perkinelmer
- Thermo Fisher
- ImmunoIVD
- Labsystems Diagnostics
Segment by Type
- Instruments
- Kits
- Software
Segment by Application
- SCID Screening
- SMA Screening
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Screening for SMA and SCID companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Kits
1.2.4 Software
1.3 Market by Application
1.3.1 Global Newborn Screening for SMA and SCID Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SCID Screening
1.3.3 SMA Screening
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn Screening for SMA and SCID Market Perspective (2019-2030)
2.2 Newborn Screening for SMA and SCID Growth Trends by Region
2.2.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Newborn Screening for SMA and SCID Historic Market Size by Region (2019-2024)
2.2.3 Newborn Screening for SMA and SCID Forecasted Market Size by Region (2025-2030)
2.3 Newborn Screening for SMA and SCID Market Dynamics
2.3.1 Newborn Screening for SMA and SCID Industry Trends
2.3.2 Newborn Screening for SMA and SCID Market Drivers
2.3.3 Newborn Screening for SMA and SCID Market Challenges
2.3.4 Newborn Screening for SMA and SCID Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Screening for SMA and SCID Players by Revenue
3.1.1 Global Top Newborn Screening for SMA and SCID Players by Revenue (2019-2024)
3.1.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Players (2019-2024)
3.2 Global Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Newborn Screening for SMA and SCID Revenue
3.4 Global Newborn Screening for SMA and SCID Market Concentration Ratio
3.4.1 Global Newborn Screening for SMA and SCID Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Screening for SMA and SCID Revenue in 2023
3.5 Newborn Screening for SMA and SCID Key Players Head office and Area Served
3.6 Key Players Newborn Screening for SMA and SCID Product Solution and Service
3.7 Date of Enter into Newborn Screening for SMA and SCID Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Screening for SMA and SCID Breakdown Data by Type
4.1 Global Newborn Screening for SMA and SCID Historic Market Size by Type (2019-2024)
4.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2025-2030)
5 Newborn Screening for SMA and SCID Breakdown Data by Application
5.1 Global Newborn Screening for SMA and SCID Historic Market Size by Application (2019-2024)
5.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Newborn Screening for SMA and SCID Market Size (2019-2030)
6.2 North America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Newborn Screening for SMA and SCID Market Size by Country (2019-2024)
6.4 North America Newborn Screening for SMA and SCID Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn Screening for SMA and SCID Market Size (2019-2030)
7.2 Europe Newborn Screening for SMA and SCID Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Newborn Screening for SMA and SCID Market Size by Country (2019-2024)
7.4 Europe Newborn Screening for SMA and SCID Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Screening for SMA and SCID Market Size (2019-2030)
8.2 Asia-Pacific Newborn Screening for SMA and SCID Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2019-2024)
8.4 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn Screening for SMA and SCID Market Size (2019-2030)
9.2 Latin America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Newborn Screening for SMA and SCID Market Size by Country (2019-2024)
9.4 Latin America Newborn Screening for SMA and SCID Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Screening for SMA and SCID Market Size (2019-2030)
10.2 Middle East & Africa Newborn Screening for SMA and SCID Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2019-2024)
10.4 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Perkinelmer
11.1.1 Perkinelmer Company Detail
11.1.2 Perkinelmer Business Overview
11.1.3 Perkinelmer Newborn Screening for SMA and SCID Introduction
11.1.4 Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2019-2024)
11.1.5 Perkinelmer Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Detail
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Newborn Screening for SMA and SCID Introduction
11.2.4 Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2019-2024)
11.2.5 Thermo Fisher Recent Development
11.3 ImmunoIVD
11.3.1 ImmunoIVD Company Detail
11.3.2 ImmunoIVD Business Overview
11.3.3 ImmunoIVD Newborn Screening for SMA and SCID Introduction
11.3.4 ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2019-2024)
11.3.5 ImmunoIVD Recent Development
11.4 Labsystems Diagnostics
11.4.1 Labsystems Diagnostics Company Detail
11.4.2 Labsystems Diagnostics Business Overview
11.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Introduction
11.4.4 Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2019-2024)
11.4.5 Labsystems Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
